Results 161 to 170 of about 13,942 (180)

Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson's disease

European Journal of Pharmacology, 1971
Lars-Ove Farnebo, Kjell Fuxe, M Goldstein   +2 more
exaly  

Amantadine

Reactions Weekly, 2016
openaire   +2 more sources

Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine

European Journal of Pharmacology, 1985
Gerald Gianutsos
exaly  

Beneficial effects of amantadine onL-dopa-induced dyskinesias in Parkinson's disease

Movement Disorders, 2000
Gregor K Wenning, Werner Poewe
exaly  

Plasma amantadine concentrations in patients with Parkinson's disease

Parkinsonism and Related Disorders, 2009
N Nishikawa
exaly  

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

Neuropharmacology, 1995
Johannes Kornhuber, G Quack, Wojciech Danysz   +2 more
exaly  

Amantadine

Reactions, 1987
openaire   +1 more source

Amantadin

1990
openaire   +1 more source

Fluorimetric liquid chromatographic analysis of amantadine in urine and pharmaceutical formulation

Journal of Chromatography A, 2005
Hsin-Lung Wu, Hwang-Shang Kou
exaly  

Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A

Antiviral Research, 1989
Peter D Reuman, David I Bernstein, Gilbert M Schiff   +2 more
exaly